Klotho Neurosciences, Inc. - Common Stock

Share · US49876K1034 · KLTO (XNAS)

No Price

05.11.2025 00:52

Current Prices from Klotho Neurosciences, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	KLTO	USD	05.11.2025 00:52	0,49 USD	0,02 USD +3,51 %

Share Float & Liquidity

Free Float 76,38 %

Shares Float 40,26 M

Shares Outstanding 52,7 M

Company Profile for Klotho Neurosciences, Inc. - Common Stock Share

Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.

Get up to date insights from finAgent about Klotho Neurosciences, Inc. - Common Stock

Company Data

Name Klotho Neurosciences, Inc. - Common Stock

Company Klotho Neurosciences, Inc.

Symbol KLTO

Website https://klothoneuro.com

Primary Exchange

NASDAQ

ISIN US49876K1034

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Joseph Sinkule

Market Capitalization 27 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 13576 Walnut Street, 68144 Omaha

IPO Date 2022-04-29

ID Changes

Date	From	To
17.09.2024	RWOD	KLTO

Ticker Symbols

Name	Symbol
NASDAQ	KLTO

More Shares

Investors who hold Klotho Neurosciences, Inc. - Common Stock also have the following shares in their portfolio:

Ambitious Plastomac Co. Ltd. Share

MOMENTUM GROUP B Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog